These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7921144)

  • 1. Developments in duodenal ulceration.
    Pounder RE
    J Gastroenterol; 1994 Jul; 29 Suppl 7():125-7. PubMed ID: 7921144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of vagotomy.
    Olbe L
    Yale J Biol Med; 1994; 67(3-4):153-7. PubMed ID: 7502524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study.
    Manes G; Domínguez-Muñoz JE; Uomo G; Labenz J; Hackelsberger A; Malfertheiner P
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):28-33. PubMed ID: 9615260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptic ulcer disease in the elderly.
    Cryer B; Feldman M
    Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
    Urakami Y; Sano T
    J Med Invest; 2003 Feb; 50(1-2):48-54. PubMed ID: 12630568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection after gastrectomy and vagotomy in duodenal ulcer patients.
    Sito E; Konturek PC; Konturek SJ; Bielański W; Stachura J
    J Physiol Pharmacol; 1996 Mar; 47(1):229-37. PubMed ID: 8777304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for eradication of Helicobacter pylori infection in duodenal ulcer disease.
    Malfertheiner P; Domínguez-Muñoz JE
    Clin Ther; 1993; 15 Suppl B():37-48. PubMed ID: 8205594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
    Gorshkov VA
    Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerogenesis: integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer.
    Peura DA
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):8S-13S; discussion 13S-16S. PubMed ID: 9127621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers.
    Greenberg PD; Koch J; Cello JP
    Am J Gastroenterol; 1996 Feb; 91(2):228-32. PubMed ID: 8607485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T; Uribe RU; Kubota T; Murakami K; Kawasaki H; Nasu M
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 19. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
    Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
    Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.